Literature DB >> 12416662

Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis.

F Lombardo1, M Valenzise, M Wasniewska, M F Messina, C Ruggeri, T Arrigo, F De Luca.   

Abstract

The aim of this study was to investigate the influence of pre-treatment variables on subsequent insulin requirement (IR) and partial remission (PR) in children with insulin-dependent diabetes mellitus (T1DM). Sixty-seven children with newly diagnosed T1DM, admitted to our Clinic during a 3-year recruitment period, were longitudinally evaluated for 2 yr. Patients were characterized by sex, age, parental education, duration of symptomatic history at diagnosis, admission duration, ketoacidosis or absence of ketoacidosis and residual beta-cell activity. More than 80% of the children experienced a PR, which lasted more than 12 months in 41.7% and at least 24 months in 16.4% of cases. The prevalence of PR at different ages after T1DM onset was significantly lower in children diagnosed while younger than 5 years than in those diagnosed after 5 years. The mean duration of the remission period was 11.7 +/- 8.9 months, irrespectively of sex, duration of the symptomatic period preceding T1DM diagnosis, parental education, blood pH and base excess, HbA1c concentration and admission duration. Beta-cell residual function evaluated after glucagons stimulation test (basal and 6 min C-peptide) was statistically different in PR patients and in those who experienced no remission. Age at diagnosis was the only pre-treatment factor which, on stepwise regression analysis, affected both PR duration and IR at the end of follow-up. To conclude, honeymoon frequency and duration are strictly conditioned by both residual beta-cell function and IR at T1DM onset. Since IR is higher in younger subjects, early onset of T1DM can be considered the factor with the most detrimental influence on honeymoon incidence. Other pre-treatment variables have no significant impact on PR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416662

Source DB:  PubMed          Journal:  Diabetes Nutr Metab        ISSN: 0394-3402


  16 in total

Review 1.  Diabetes mellitus: The epidemic of the century.

Authors:  Akram T Kharroubi; Hisham M Darwish
Journal:  World J Diabetes       Date:  2015-06-25

2.  Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.

Authors:  Annelien Van Dalem; Simke Demeester; Eric V Balti; Katelijn Decochez; Ilse Weets; Evy Vandemeulebroucke; Ursule Van de Velde; An Walgraeve; Nicole Seret; Christophe De Block; Johannes Ruige; Pieter Gillard; Bart Keymeulen; Daniel G Pipeleers; Frans K Gorus
Journal:  Diabetologia       Date:  2015-09-26       Impact factor: 10.122

3.  Partial Clinical Remission of Type 1 Diabetes Mellitus in Children: Clinical Applications and Challenges with its Definitions.

Authors:  Benjamin Udoka Nwosu
Journal:  Eur Med J Diabetes       Date:  2019-03-14

4.  Early Initiation of Intermittently Scanned Continuous Glucose Monitoring in a Pediatric Population With Type 1 Diabetes: A Real World Study.

Authors:  Roberto Franceschi; Vittoria Cauvin; Lorenza Stefani; Federica Berchielli; Massimo Soffiati; Evelina Maines
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

5.  Phase transitions in pancreatic islet cellular networks and implications for type-1 diabetes.

Authors:  I J Stamper; Elais Jackson; Xujing Wang
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2014-01-27

6.  Phenotypical and genotypical expression of Wolfram syndrome in 12 patients from a Sicilian district where this syndrome might not be so infrequent as generally expected.

Authors:  F Lombardo; G Salzano; C Di Bella; T Aversa; F Pugliatti; S Cara; M Valenzise; F De Luca; L Rigoli
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

7.  A pilot study showing associations between frequency of CD4(+) memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes.

Authors:  Rosita Moya; Hannah Kathryn Robertson; Dawson Payne; Aditi Narsale; Jim Koziol; Joanna Davida Davies
Journal:  Clin Immunol       Date:  2016-04-22       Impact factor: 3.969

8.  Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis.

Authors:  Eda Cengiz; Crystal G Connor; Katrina J Ruedy; Roy W Beck; Craig Kollman; Georgeanna J Klingensmith; William V Tamborlane; Joyce M Lee; Michael J Haller
Journal:  Pediatr Diabetes       Date:  2013-08-15       Impact factor: 4.866

9.  Institution of basal-bolus therapy at diagnosis for children with type 1 diabetes mellitus.

Authors:  Soumya Adhikari; Beverley Adams-Huet; Yu-Chi A Wang; James F Marks; Perrin C White
Journal:  Pediatrics       Date:  2009-03-02       Impact factor: 7.124

Review 10.  Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

Authors:  Brett Phillips; Massimo Trucco; Nick Giannoukakis
Journal:  Clin Dev Immunol       Date:  2011-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.